Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingrong Xia

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
BMC Psychiatry|December 31, 2024
Peripheral blood complement factors C2 and C3 as biomarkers of clinical efficacy in patients with first-episode schizophrenia after aripiprazole treatmentYin Cao, Jun Liang, Biao Dai, et al.
Annals of General Psychiatry|October 1, 2025
Associations of ANKK1 (rs1800497) polymorphism with glucose and lipid metabolism in patients with schizophrenia treated with olanzapine: a retrospective studyWenfan Gao, Yayun Xu, Feng Shan, et al.
Neuropsychiatric Disease and Treatment|November 12, 2020
Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in ChinaYang Liu, Jun Liang, Qingrong Xia, et al.
Journal of Molecular Neuroscience : MN|May 12, 2026
The Liver-brain Axis: A Three-stage Model Linking MASLD to Cognitive Impairment and DementiaLijuan Nie, Yinglian Zhao, Wanbin Liu, et al.
Neuropsychiatric Disease and Treatment|June 29, 2023
Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode SchizophreniaYin Cao, Yayun Xu, Qingrong Xia, et al.
Current Medical Imaging|March 23, 2022
Interdisciplinary Collaboration Opportunities, Challenges, and Solutions for Artificial Intelligence in UltrasoundQingrong Xia, Meng Du, Bin Li, et al.
Annals of General Psychiatry|March 29, 2026
Alterations in serum melatonin, IL-6 and BDNF levels and their clinical correlations in first-episode major depressive disorderChunyu Yan, Yayun Xu, Jun Liang, et al.
Annals of General Psychiatry|June 28, 2026
Association between changes in sleep quality and serum pro-inflammatory cytokine levels in patients with major depressive disorder following duloxetine treatmentYayun Xu, Wenfan Gao, Feng Shan, et al.
Neuropsychiatric Disease and Treatment|August 19, 2024
Effect of Common Cold on Serum Clozapine Concentrations in Hospitalized Patients with SchizophreniaYin Cao, Qingrong Xia, Jun Liang, et al.
BMC Psychiatry|October 9, 2025
Effect of olanzapine on changes in serum complement factors levels in patients with first-episode schizophreniaYin Cao, Xuan Zhou, Chunyu Yan, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
BMC Psychiatry|December 31, 2024
Peripheral blood complement factors C2 and C3 as biomarkers of clinical efficacy in patients with first-episode schizophrenia after aripiprazole treatmentYin Cao, Jun Liang, Biao Dai, et al.
Annals of General Psychiatry|October 1, 2025
Associations of ANKK1 (rs1800497) polymorphism with glucose and lipid metabolism in patients with schizophrenia treated with olanzapine: a retrospective studyWenfan Gao, Yayun Xu, Feng Shan, et al.
Neuropsychiatric Disease and Treatment|November 12, 2020
Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in ChinaYang Liu, Jun Liang, Qingrong Xia, et al.
Journal of Molecular Neuroscience : MN|May 12, 2026
The Liver-brain Axis: A Three-stage Model Linking MASLD to Cognitive Impairment and DementiaLijuan Nie, Yinglian Zhao, Wanbin Liu, et al.
Neuropsychiatric Disease and Treatment|June 29, 2023
Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode SchizophreniaYin Cao, Yayun Xu, Qingrong Xia, et al.
Current Medical Imaging|March 23, 2022
Interdisciplinary Collaboration Opportunities, Challenges, and Solutions for Artificial Intelligence in UltrasoundQingrong Xia, Meng Du, Bin Li, et al.
Annals of General Psychiatry|March 29, 2026
Alterations in serum melatonin, IL-6 and BDNF levels and their clinical correlations in first-episode major depressive disorderChunyu Yan, Yayun Xu, Jun Liang, et al.
Annals of General Psychiatry|June 28, 2026
Association between changes in sleep quality and serum pro-inflammatory cytokine levels in patients with major depressive disorder following duloxetine treatmentYayun Xu, Wenfan Gao, Feng Shan, et al.
Neuropsychiatric Disease and Treatment|August 19, 2024
Effect of Common Cold on Serum Clozapine Concentrations in Hospitalized Patients with SchizophreniaYin Cao, Qingrong Xia, Jun Liang, et al.
BMC Psychiatry|October 9, 2025
Effect of olanzapine on changes in serum complement factors levels in patients with first-episode schizophreniaYin Cao, Xuan Zhou, Chunyu Yan, et al.
Pageof 6